Posted in | News | Energy

Shell and Codexis Partner to Explore Next-Generation Bio-Fuels

Shell Oil Products US, a subsidiary of Shell Oil Company, and Codexis Inc., a privately held biotechnology company, announced today they would launch a collaboration to explore enhanced methods of converting biomass to bio-fuels. Terms of the agreement were not disclosed.

"Shell is committed to leading the development of second-generation bio- fuels that offer lower well-to-wheel CO2 production and enhanced performance," David Sexton, President, Shell Oil Products US, said. "We are exploring the application of Codexis' proprietary technologies to produce alternative fuels from renewable, sustainable sources."

"Our proven biocatalytic approach should provide the critical pathway to developing economically feasible alternative transportation fuels from renewable resources," Alan Shaw, Ph.D., Codexis President and Chief Executive Officer, said. "We are pleased to be partnering with Shell, a world leader in energy, to undertake this important effort."

Shell has been involved in developing bio-fuels for more than 30 years, and believes it is the world's largest distributor of transport bio-fuels today. The company sold nearly 800 million gallons (3 billion liters) of bio- fuel in 2005, mostly in the United States and Brazil. Shell also markets fuels containing bio-components in Australia, France, Germany, Italy, the Philippines, Sweden and Thailand.

Shell Oil Products US, a subsidiary of Shell Oil Company, is a leader in the refining, transportation and marketing of fuels, and has a network of approximately 6,000 branded gasoline stations in the Western United States.

http://www.codexis.com and http://www.shell.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.